Literature DB >> 17053596

Endovascular management of cerebral vasospasm.

Marike Zwienenberg-Lee1, Jonathan Hartman, Nancy Rudisill, Jan Paul Muizelaar.   

Abstract

Cerebral vasospasm remains a leading cause of death and disability in patients with ruptured cerebral aneurysms. The development of endovascular intervention in the past two decades has shown promising results in the treatment of vasospasm. Endovascular techniques that have been used in humans include intra-arterial infusion of vasorelaxants and direct mechanical dilation with transluminal balloon angioplasty. This article reviews the current indications and role of endovascular therapy in the management of cerebral vasospasm, its clinical significance, and potential future therapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17053596     DOI: 10.1227/01.NEU.0000239252.07760.59

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  10 in total

1.  Intensive care unit management of aneurysmal subarachnoid hemorrhage.

Authors:  Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

2.  Unsecured intracranial aneurysms and induced hypertension in cerebral vasospasm: is induced hypertension safe?

Authors:  Johannes Platz; Erdem Güresir; Hartmut Vatter; Joachim Berkefeld; Volker Seifert; Andreas Raabe; Jürgen Beck
Journal:  Neurocrit Care       Date:  2011-04       Impact factor: 3.210

Review 3.  Posttraumatic vasospasm detected by continuous brain tissue oxygen monitoring: treatment with intraarterial verapamil and balloon angioplasty.

Authors:  Kiarash Shahlaie; James E Boggan; Richard E Latchaw; Cheng Ji; J Paul Muizelaar
Journal:  Neurocrit Care       Date:  2008-09-20       Impact factor: 3.210

4.  Safety and efficacy of transluminal balloon angioplasty using a compliant balloon for severe cerebral vasospasm after an aneurysmal subarachnoid hemorrhage.

Authors:  Beom Jin Choi; Tae Hong Lee; Jae Il Lee; Jun Kyeung Ko; Hwa Seung Park; Chang Hwa Choi
Journal:  J Korean Neurosurg Soc       Date:  2011-03-31

Review 5.  Management of aneurysmal subarachnoid hemorrhage.

Authors:  Michael N Diringer
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

6.  Role of calcitonin gene-related peptide in cerebral vasospasm, and as a therapeutic approach to subarachnoid hemorrhage.

Authors:  Stelios Kokkoris; Peter Andrews; David J Webb
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-15       Impact factor: 5.555

7.  Admission risk factors for cerebral vasospasm in ruptured brain arteriovenous malformations: an observational study.

Authors:  Vibol Chhor; Yannick Le Manach; Fréderic Clarençon; Aurélien Nouet; Jean-Louis Daban; Lamine Abdennour; Louis Puybasset; Thomas Lescot
Journal:  Crit Care       Date:  2011-08-10       Impact factor: 9.097

8.  Simultaneous endovascular treatment of ruptured cerebral aneurysms and vasospasm.

Authors:  Young Dae Cho; Moon Hee Han; Jun Hyong Ahn; Seung Chai Jung; Chang Hun Kim; Hyun-Seung Kang; Jeong Eun Kim; Jeong Wook Lim
Journal:  Korean J Radiol       Date:  2015-01-09       Impact factor: 3.500

Review 9.  Towards use of MRI-guided ultrasound for treating cerebral vasospasm.

Authors:  Robert H Bonow; John R Silber; Dieter R Enzmann; Norman J Beauchamp; Richard G Ellenbogen; Pierre D Mourad
Journal:  J Ther Ultrasound       Date:  2016-02-29

10.  Angioplasty with the scepter C dual lumen balloon catheter and postprocedural result evaluation in patients with subarachnoid hemorrhage related vasospasms.

Authors:  Ioannis Tsogkas; Vesna Malinova; Katharina Schregel; Dorothee Mielke; Daniel Behme; Veit Rohde; Michael Knauth; Marios-Nikos Psychogios
Journal:  BMC Neurol       Date:  2020-06-29       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.